e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
Steven D. Nathan, Ming Yang, Elizabeth A. Morgenthien, John L. Stauffer
Source:
Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019
Journal Issue:
May
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Steven D. Nathan, Ming Yang, Elizabeth A. Morgenthien, John L. Stauffer. FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change. Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Relationship between six-minute walk test and resting lung function in patients with IPF
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1822-1823
Year: 2014
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1823-1824
Year: 2014
The influence of selected sociodemographic parameters on the results of 6-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 243s
Year: 2004
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD
Source: Eur Respir J 2004; 23: 28-33
Year: 2004
Dynamic hyperinflation during the 6-minute walk test and incremental cycling exercise in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 121s
Year: 2004
Analysis of changes in clinical characteristics of patients with COPD or interstitial pneumonia during a 6-minute walk test
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020
Challenges in idiopathic pulmonary fibrosis trials: the point on end-points
Source: Eur Respir Rev 2011; 20: 195-200
Year: 2011
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1421-1429
Year: 2014
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 31: 1183-1188
Year: 2008
The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Is 6-min walk distance more helpful than FEV1 in evaluating severe COPD patients?
Source: ISSN=ISSN 1810-6838, ISBN=, page=68
Year: 2007
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 96-103
Year: 2005
Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 16s
Year: 2005
Oxygen desaturation-resaturation and heart rate change patterns during 6-min walk test in patients with mild to severe interstitial pneumonia
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018
Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 564-569
Year: 2002
Association between six minute walk test and expiratory spirometry parameters in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 64s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept